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Résumé 
 
 La période de réceptivité endométriale chez l’humain coïncide avec la différentiation 
des cellules stromales de l’endomètre en cellules hautement spécifiques, les cellules 
déciduales, durant le processus dit de décidualisation. Or, on sait qu’une transformation 
anormale des cellules endométriales peut être à l’origine de pertes récurrentes de 
grossesses.  
 LRH-1 est un récepteur nucléaire orphelin et un facteur de transcription régulant de 
nombreux évènements relatif à la reproduction et comme tout récepteur, son activation 
promouvoit l’activité transcriptionnelle de ses gènes cibles. Nous avons déjà montré que 
LRH-1 et son activité sont essentiels pour la décidualisation  au niveau de l’utérus chez la  
souris et nous savons qu’il est présent dans l’utérus chez l’humain au moment de la phase de 
prolifération mais aussi de sécrétion du cycle menstruel, et que son expression augmente 
dans des conditions de décidualisation in vitro.  
 Notre hypothèse est alors la suivante : LRH-1 est indispensable à la décidualisation du 
stroma endométrial, agissant par le biais de la régulation transcriptionnelle de gènes requis 
pour la transformation de cellules stromales en cellules déciduales.  
 Afin d’explorer le mécanisme moléculaire impliqué dans la régulation 
transcriptionnelle effectuée par l’intermédiaire de ce récepteur, nous avons mis en place un 
modèle de décidualisation in vitro utilisant une lignée de cellules stromales de l’endomètre, 
cellules humaines et immortelles (hESC). Notre modèle de surexpression développé en 
transfectant les dites cellules avec un plasmide exprimant LRH-1, résulte en l’augmentation, 
d’un facteur 5,  de l’abondance du transcriptome de gènes marqueurs de la décidualisation 
que sont la prolactine (PRL) et l’insulin-like growth factor binding protein-1 (IGFBP-1). En 
outre, la sous-régulation de ce récepteur par l’intermédiaire de petits ARN interférents 
(shRNA) abolit la réaction déciduale, d’un point de vue morphologique mais aussi en terme 
d’expression des deux gènes marqueurs cités ci-dessus. Une analyse par Chromatin 
ImmunoPrécipitation (ou ChIP) a démontré que LRH-1 se lie à des régions génomiques se 
trouvant en aval de certains gènes importants pour la décidualisation comme PRL, WNT 4, 
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WNT 5, CDKN1A ou encore IL-24, et dans chacun de ces cas cités, cette capacité de liaison 
augmente dans le cadre de la décidualisation in vitro.  
 Par ailleurs, des études structurelles ont identifié les phospholipides comme des 
ligands potentiels pour LRH-1. Nous avons donc choisi d’orienter notre travail de façon à 
explorer les effets sur les ligands liés à LRH-1 de traitements impliquant des agonistes et 
antagonistes à notre récepteur nucléaire. Les analyses par q-PCR et Western blot ont montré 
que la modulation de l’activité de LRH-1 par ses ligands influait aussi sur la réaction 
déciduale.  
 Enfin, des études récentes de Salker et al (Salker, Teklenburg et al. 2010) ont mis en 
évidence que les cellules stromales humaines décidualisées sont de véritables biocapteurs de 
la qualité embryonnaire et qu’elles ont la capacité de migrer en direction de l’embryon. La 
série d’expériences que nous avons réalisée à l’aide de cellules hESC placées en co-culture 
avec des embryons de souris confirme que la migration cellulaire est bien dirigée vers les 
embryons. Cette propriété quant à l’orientation de la migration cellulaire  est notoirement 
diminuée dans le cas où l’expression de LRH-1 est déplétée par shRNA dans les hESC.  
Nos données prouvent donc que LRH-1 régule non seulement la transcription d’un ensemble 
de gènes impliqués dans le processus de décidualisation mais agit aussi sur la motilité 
directionnelle de ces cellules hESC décidualisées in vitro.  
 
Mots-clés: LRH-1, décidualisation, immunoprécipitation de la chromatine, ligands, co-culture. 
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Abstract 
 
 The period of endometrial receptivity in humans coincides with the differentiation of 
endometrial stromal cells into highly specialized decidual cells through a process known as 
decidualization. This transformation of endometrial cells is abnormal in recurrent pregnancy 
loss patients. Liver homolog receptor 1 (LHR-1, NR5A2) is an orphan nuclear receptor and a 
transcription factor that regulates many reproductive events. The activation of this receptor 
leads to transcriptional activation of its target genes.  We have previously shown that it is 
essential for decidualization in the mouse uterus.  LRH-1 is expressed in the human uterus in 
both proliferative and secretory phases of the menstrual cycle and its expression increases 
during in vitro decidualization.  We hypothesize that LRH-1 is indispensable for proper 
decidualization of the endometrial stroma, acting through the transcriptional regulation of 
genes required for transformation of stromal cells into decidual cells.  To explore the 
molecular mechanism of transcriptional regulation mediated by this receptor, we established 
an in vitro model of decidualization, using an immortal human endometrial stromal cell line 
(hESC).  An overexpression model developed by transfecting the cells with a plasmid 
constitutively expressing Lrh-1, resulted in 5 fold increases in abundance of transcripts for 
the decidualization marker genes prolactin (PRL) and insulin-like growth factor binding 
protein-1 (IGFBP-1). Furthermore, the downregulation of the receptor using short hairpin 
RNA (shRNA) abrogates the decidual reaction, from both a morphological point of view and 
in terms of expression of the two marker genes. Chromatin immunoprecipitation (ChIP)  
analysis showed that LRH-1 binds to genomic regions upstream  of genes important for 
decidualization such as PRL, wingless-type MMTV integration site family, member 4 (WNT4), 
wingless-type MMTV integration site family, member 5 (WNT5), cyclin-dependent kinase 
inhibitor 1A (p21, CDKN1A) and interleukin-24(IL-24). For each of these genes, the binding 
increased  during in vitro decidualization.  Structural studies have identified phospholipids as 
potential LRH-1 ligands.  We therefore explored the effect of ligand treatment on LRH-1 with 
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an agonist and an inverse agonist for the nuclear receptor. Analysis by quantitative 
polymerase chain reaction (qPCR) and Western blot demonstrated that the modulation of 
LRH-1 activity by its ligands also affects the decidual reaction. Recent studies have shown 
that  decidualized human stromal cells are biosensors of embryo quality and that they have 
the capacity to migrate towards the embryo. Our time-lapse evaluation of hESC cells co-
cultured with mouse embryos indicates directed migration of the cells toward the embryo.  
This effect is markedly diminished when LRH-1 is depleted by shRNA in hESC.   Our data 
provide evidence that LRH-1 regulates not only the transcription of a set of genes involved in 
decidualization but also the directional motility of these cells in vitro. 
 
Keywords: LRH-1, decidualization, chromatin immunoprecipitation, ligands, co-culture. 
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1. Introduction 
 
 Human reproduction is an inefficient event, only 30% of cycles at risk of pregnancy 
result in live birth (Macklon, Geraedts et al. 2002). Since 1978, when the first in vitro 
conceived baby was born (Steptoe and Edwards 1978), in vitro fertilization has become one 
of the most important methods for treating infertility. The causes of infertility comprise 
many different elements, including ovulatory, uterine and male factor dysfunction. 
 
 Implantation is the process by which the embryo comes into intimate physical and 
physiological contact with the uterine endometrium (Dey, Lim et al. 2004). For this to occur, 
the embryo must attach to a receptive endometrium and then invade the decidualizing 
stroma (Koot, Teklenburg et al. 2012). The human decidualization process is initiated in the 
mid-secretory phase of the menstrual cycle, and involves transformation of the elongated 
fibroblast-like endometrial stromal cells to larger secretory decidual cells. Proper 
decidualization of endometrial stroma is critical to the establishment of pregnancy 
(Gellersen, Brosens et al. 2007). 
 
 Elucidation of the early embryo implantation mechanisms at the molecular level in 
human is important to further understand fertility disorders. The steroid hormones, estrogen 
and progesterone, via their receptors, play critical roles in uterine receptivity, implantation, 
and decidualization. Other members of the nuclear receptor family have also been described 
to have a potential role in endometrial function (Vasquez and DeMayo 2013). Nuclear 
receptors are also major targets for drug discovery and have key roles in development and 
homeostasis, as well as in many diseases, such as diabetes, cancer and reproductive 
disorders (Gronemeyer, Gustafsson et al. 2004). 
 
 LRH-1 is an orphan nuclear receptor and a critical regulator of multiple mechanisms 
essential for female fertility (Duggavathi, Volle et al. 2008). LRH-1 is expressed in the ovary, 
exclusively in granulosa and luteal cells, and early transgenic deletion of Lrh-1 in granulosa 
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cells abolishes ovulation in mice (Duggavathi, Volle et al. 2008). Recent studies demonstrated 
that LRH-1 is also expressed in the endometrium during proliferative and secretory phases of 
the mouse estrous cycle and it has a role in modulating responsiveness of endometrial 
stromal cells to decidualizing stimulus (Zhang, Large et al. 2013).  As noted above, it is also 
expressed in the human endometrium and may be essential for proper decidualization 
(Zhang, Large et al. 2013). 
 
 Salker et al. (2010) have previously reported that hESCs become sensitive to 
embryonic signals upon differentiation into decidual cells and respond selectively to the 
presence of human embryos by secreting key implantation factors, including interleukin-1 
beta, heparin-binding EGF-like growth factor, and leukemia inhibitory factor (Salker, 
Teklenburg et al. 2010). In addition, decidualized cells demonstrate a strong motile response 
to the presence of an embryo (Weimar, Kavelaars et al. 2012). 
 
 Given the pattern of expression of LRH-1 and its apparent importance to 
decidualization, our goals in this project were to elucidate the role of LRH-1 using a human 
endometrial stromal cell line model.  With this model, we have studied the effects of LRH-1 
overexpression and conditional deletion of this receptor. We hypothesized that LRH-1 
transcriptionally regulates genes involved in decidualization in human endometrial stromal 
cells. We have also explored the effect on LRH-1 ligands in hESCs by treatment with an 
agonist and an inverse agonist for the nuclear receptor. Moreover, we have established a co-
culture model using hESCs and mouse embryos to further explore the effects of LRH-1 
expression in the migratory response of decidual cells in vitro.  Together, these findings 
permit inference of the role of LRH-1 on fertility and the uterine reproductive phenotype 
during early stages of pregnancy. 
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2. Literature review 
 
2.1. Implantation and decidualization 
 
 Implantation is the process by which the blastocyst comes into contact with the 
uterine endometrium. This process involves a reciprocal communication between the 
blastocyst and uterus and is essential for continued embryonic development within the 
uterus and for achievement of successful pregnancy (Das 2009). Implantation is a complex 
process that is both temporally and spatially restricted in that there is only a specific period 
of time when the uterus is receptive to implantation. This period of uterine receptivity is 
known as the "window of implantation" (Nikas and Psychoyos 1997). Changes in the 
endometrium are essential to allow the establishment of pregnancy. Uterine differentiation 
to support blastocyst implantation is induced in vivo by progesterone and estrogen, and 
includes changes in the stromal cells, which undergo a characteristic decidual reaction (Dunn, 
Kelly et al. 2003). Decidualization is a process characterized by stromal cell proliferation and 
differentiation, whereby stromal cells are transformed into large, secretory decidual cells. 
This occurs prior to implantation in humans, and following implantation in mice, triggered in 
the latter case by the presence of the implanting embryo (Cha, Sun et al. 2012). 
 
 Between day 5 afternoon and day 6 morning following mating (day post copulation or 
dpc), in the adult mouse, the blastocyst initiates implantation on the antimesometrial pole of 
the uterus.  The stromal cells surrounding the implanting embryo cease proliferation and 
undergo differentiation into decidual cells (Das 2009). The first manifestation is the 
formation of the vascular primary decidual zone and secondary decidual zone is formed 
around the primary zone by dpc 8 to replace the primary zone (Das 2010). In 
pseudopregnant, or in ovariectomized, hormonally conditioned mice, a decidual reaction can 
be induced by insult to the endometrial lining. In rodents, decidualization occurs with the 
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acquisition of cell polyploidy, a feature of decidual cells (Abrahamsohn and Zorn 1993). 
Decidual cell polyploidy is characterized by the occurrence of nuclear endoduplication, 
consisting in variation of the canonical G1–S–G2–M cell cycle that replicates the genome 
without cell division (Tan, Raja et al. 2002). 
 
 As reviewed by Brosens et al. (2007), in humans, uterine receptivity is also regulated 
by the ovarian steroid hormones, estrogen and progesterone. During the follicular phase of 
the menstrual cycle, there is an increase in the secretion of ovarian estrogen which then 
stimulates proliferation of the uterine stromal and epithelial compartments. (Gellersen, 
Brosens et al. 2007). Upon ovulation, differentiation of the ovarian granulosa cells into the 
corpus luteum results in the production of progesterone in the ovary that triggers the 
decidual reaction, which makes the endometrium receptive to embryo implantation and 
drives the differentiation of stromal cells to decidual cells (Gellersen, Brosens et al. 2007).  As 
noted above, this remodelling process is critical for embryo development, placental 
formation and pregnancy maintenance. Decidualization failure in humans is associated with 
various female reproductive disorders, such as pre-eclampsia and recurrent miscarriages 
(Gellersen and Brosens 2003). Furthermore, recent studies suggest that decidualized stromal 
cells are biosensors of human embryo quality, dictating survival of early gestation (Salker, 
Teklenburg et al. 2010). 
 
2.2. Nuclear receptors 
 
 Nuclear receptors are ligand-dependent transcription factors that play important 
roles in several biological processes, including cell proliferation, differentiation, cellular 
homeostasis and metabolism, and are associated with numerous pathologies such as cancer, 
cardiovascular disease, inflammation, and reproductive abnormalities (Aranda and Pascual 
2001).  They are one of the largest groups of transcription factors in mammals. Evolutionary 
analysis of the receptors, together with sequencing of the human genome has led to the 
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identification of 48 human nuclear receptors and allowed for the classification in six different 
subfamilies (Robinson-Rechavi, Carpentier et al. 2001).  The orphan receptors were defined 
as molecules that had the structural characteristics of the nuclear receptor family, but for 
which the ligand was yet to be identified (Alexander, Mathie et al. 2004).  When the ligands 
have been discovered, these receptors then become the “adopted” nuclear receptors, no 
longer orphans.  The subfamilies of the nuclear receptors include a large aggregation formed 
by thyroid hormone receptors, retinoic acid receptors, vitamin D receptors and adopted 
peroxisome proliferator-activated receptors as well as other orphan receptors.  A second 
subfamily contains the retinoid X receptors together with chicken ovalbumin upstream 
stimulators, hepatocyte nuclear factor 4, testis receptors and receptors involved in eye 
development. The third, and best known family is formed by steroid receptors and the highly 
related orphan receptors known as the estrogen-related receptors. The fourth, fifth and sixth 
subfamilies contain the orphan receptors nerve growth factor IB (NGFI-B, NR4A1), LRH-1, 
steroidogenic factor 1 (FTZ-1/SF-1) and germ cell nuclear factor (GCNF) respectively (Laudet 
1997). 
 
 The nuclear receptors are believed to be evolutionarily derived from a common 
ancestor. Indeed, most of the nuclear receptors subfamilies appear to be ancient since they 
have arthropod and other invertebrate homologs (Aranda and Pascual 2001). The  exception 
is the steroid receptors that have no known homologs. It has been suggested that the 
ancestral receptors were constitutive homodimeric transcription factors that evolved to 
independently acquire the ability to bind ligands and to heterodimerize. However, the 
possibility that the ancestral receptor was ligand dependent, and that mutations changed the 
ligand-binding specificity or led to loss of ligand binding during evolution, cannot be ruled out 
(Aranda and Pascual 2001). 
 
 Some nuclear receptors are activated or inhibited by hormones, others by vitamins, 
fatty acids or bile acid (Kliewer, Lehmann et al. 1999). The natural ligands fit into binding 
pockets of the nuclear receptors (Glass and Ogawa 2006). By designing drugs that in a similar 
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manner bind to the nuclear receptors, gene expression can be affected, which is useful in 
treating many diseases and medical conditions (Mukherjee and Mani 2010).  
 
2.2.1. General structure 
 
 Nuclear receptors contain several functional domains that are defining structural 
features for members of the nuclear receptor superfamily (Fig. 1). In general, members of 
this family contain an N-terminal transactivation domain (AF-1), a highly conserved central 
region zinc-finger DNA binding domain (DBD), and a C-terminal ligand-binding domain (LBD) 
and a second activation domain, AF-2, which is located at the carboxy-terminal end of the 
LBD and mediates ligand-dependent transactivation by nuclear receptors (Shi 2007). 
 
Fig.1. General structure of nuclear receptors. Primary, secondary and tertiary structure of the 
nuclear receptor domains. (Nuclear receptor resource http://nrresource.org/) 
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2.2.2. Nuclear receptors modulation: Ligands, coactivators and corepressors 
 
 The main function of nuclear receptors is transcriptional regulation of target genes in 
response to hormones and other ligands (Wurtz, Bourguet et al. 1996). To do so, they recruit 
both positive and negative specific regulatory proteins, referred to as coactivators or co-
repressors (Manteuffel-Cymborowska 1999). Ligand-dependent activation of transcription is 
mediated by interactions with coactivators, while co-repressors mediate active repression of 
unliganded nuclear receptors (Shi 2007).  
 
 Co-repressors usually form complexes that contain histone deacetylase activity 
(Laherty, Yang et al. 1997). The deacetylation process leads to chromatin compaction and 
subsequent transcriptional repression. For the ligand-dependent activation, the receptors 
undergo a conformational change that allows the recruitment of multiple coactivator 
complexes (Chen, Lin et al. 1997). Some of these proteins are chromatin remodeling factors, 
and possess histone acetylase activity, whereas others may interact directly with the basic 
transcriptional machinery (Laherty, Yang et al. 1997). Recruitment of coactivator complexes 
to the target promoter leads on chromatin decompaction and transcriptional activation of 
the target genes (Aranda and Pascual 2001). 
 
 In recent years new ligands have been discovered for many nuclear receptors. 
Tamoxifen is a synthetic ligand used as a modulator for estrogen receptor activity (No 
authors listed, 1988). It is an specific antagonist of the estrogen receptor in breast tissue and 
an essential drug for treatment of breast cancer (Jordan 1976). Peroxisome proliferator-
activated receptors (PPARs) are promising target genes for the treatment of diabetes and 
obesity due to their role in regulating glucose and lipid metabolism (Tobin and Freedman 
2006) and the orphan nuclear receptor subfamily 2 group E member 1(NR2E1, TLX) is a 
potential pharmacological target for drug discovery in neurodegenerative diseases as it is an 
essential regulator of neural stem cell maintenance and self-renewal in the adult brain (Shi, 
Chichung Lie et al. 2004). 
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 One of the most promising aspects of nuclear receptor pharmacology is the possibility 
of developing not only ligands, but also compounds, called selective nuclear receptor 
modulators, that activate only a subset of functions or that act in a cell-type-selective 
manner (Gronemeyer, Gustafsson et al. 2004). 
 
2.3. Molecular features of decidualization 
 
 Decidualized stromal cells are derived from the fibroblast-like cells within the 
endometrium, which maintain their progesterone receptors in the presence of progesterone 
(Dunn, Kelly et al. 2003). Prolonged exposure to progesterone induces a rounded cell 
characterized by the release of Prolactin (PRL) and Insuline grow factor binding protein 1 
(IGFBP-1). In vitro, elevated intracellular cyclic adenosine monophosphate (cAMP) as well as 
progesterone is necessary for decidualization. In vivo, these conditions may be provided by 
progesterone from the corpus luteum, by prostaglandin E, a stimulator of adenylcyclase, and 
relaxin, which has been shown to be a phosphodiesterase inhibitor (Tamaya, Fujimoto et al. 
1985). Given the co-distribution of uterine natural killer cells and decidualized stromal cells, a 
mutual interaction might provide the appropriate regulatory environment for successful 
implantation, and penetration of the maternal blood vessels by trophoblastic cells (Dunn, 
Kelly et al. 2003). 
 
2.3.1. Nuclear receptors and decidualization 
 
 As noted above, the uterus is a hormone-sensitive organ that responds to the 
presence of female ovarian hormones, estrogen and progesterone. These hormones act via 
their nuclear receptors to direct the transcriptional activity of the endometrial compartments 
(Vasquez and DeMayo 2013). Nuclear receptors present specific expression patterns through 
the window of implantation in the endometrium (Vasquez and DeMayo 2013). 
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 Many nuclear receptors have been described to have a potential role in endometrial 
function. Much of what we know about the function of these nuclear receptors during 
implantation we have learned from the use of transgenic murine models with targeted gene 
ablation. These models have helped to define the molecular mechanisms involved in the 
acquisition of the receptive uterine environment, providing a useful tool to help improve the 
fertility outlook for reproductively challenged couples (Vasquez and DeMayo 2013). 
 
 Conditional ablation of the bone morphogenetic protein 2 receptor (BMPR2) in the 
mouse uterus leads to female infertility, primarily due to a defect in stromal decidualization, 
caused by the disregulation of the Cyclin D3 (Ccnd3), a key mediator of G2 phase arrest in 
decidualizing stromal cells (Chiang 2003).  Bmpr2 conditional knock out (cKO) mice exhibit 
decidual growth restriction and vascularization anomalies (Nagashima, Li et al. 2013). Both, 
cKO mice for the estrogen receptor-α (Esr1) and progesterone receptor A (Prg) present 
multiple reproductive abnormalities, including implantation and decidualization defects 
(Lydon, DeMayo et al. 1995) (Lubahn, Moyer et al. 1993). Androgen receptors also seem to 
play an important role in the regulation of a distinct set of genes during in vitro 
decidualization in hESC. Androgen receptor depletion disregulates the expression of genes 
involved in cytoskeletal organization, cell motility and cell cycle regulation (Cloke, Huhtinen 
et al. 2008). PPAR expression plays a critical role in placental function, intrauterine growth 
restriction, inflammatory pathways, and mediates cyclooxygenase-2 (COX2)-derived 
prostacyclin signaling during pregnancy (Majed and Khalil 2012). Some orphan nuclear 
receptors have been also shown to play a role in stromal decidualization. The nuclear 
receptor subfamily 2, group F, member 2 (COUP-TFII, NR2F2) cKO mouse with depletion in 
the endometrium shows defects in blastocyst attachment and an absent decidual response 
(Lee, Jeong et al. 2006).  COUP-TFII also plays a central role in the stromal-epithelial crosstalk 
during implantation, by regulating the WNT and BMP pathways (Lee, Kurihara et al. 2010). 
SF-1 and LRH-1 interact with the same DNA sequence. SF-1 is expressed mainly in testis, 
granulosa and theca cells of the ovary, adrenal cortex, pituitary and hypothalamus (Nomura, 
Kawabe et al. 1998). LRH-1 is involved in regulation of several physiological systems, 
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including the liver, pancreas and intestine (Fayard, Auwerx et al. 2004). LRH-1 is not only 
expressed in tissues of endodermal origins but also in steroidogenic tissues, such as pre-
adipocytes (Clyne, Speed et al. 2002), the ovary (Boerboom, Pilon et al. 2000), and the testis 
(Sirianni, Seely et al. 2002). While SF-1 expression in the endometrium is silenced due to a 
promoter methylation, and it is aberrantly activated in endometriosis (Bulun, Utsunomiya et 
al. 2009). Recent studies demonstrated that LRH-1 is expressed in the uterus in both human 
and mice (Zhang, Large et al. 2013). 
 
2.4. LRH-1 in reproduction 
 
 As indicated above, LRH1 is an orphan nuclear receptor. It belongs to the four-
member NR5A, or Ftz-F1, subfamily V of nuclear receptors (Galarneau, Pare et al. 1996).  
Murine LRH-1 was originally identified due to its sequence homology to Drosophila 
Fushitarazu factor-1 (Taketo, Parker et al. 1995). Orthologs were subsequently identified in 
other species including rat, chicken, horse, zebrafish and human (Busby, Nuhant et al. 2010). 
In mammals, LRH-1 is predominantly expressed in endoderm-derived organs such as the 
liver, the pancreas, and the intestine. (Fayard, Auwerx et al. 2004). LRH-1 was also shown to 
be expressed early during mouse embryogenesis (Hinshelwood, Shelton et al. 2005). 
Consistent with its early expression pattern, a targeted disruption of this gene leads to 
embryonic lethality around the gastrulation period (Labelle-Dumais, Jacob-Wagner et al. 
2006). 
 
 Like many other nuclear receptors, LRH-1 displays pleiotropic functions, it is known to 
participate in several processes related to metabolism, immune function, cell proliferation 
and reproduction (Bain, Heneghan et al. 2007). Unlike other nuclear receptors that function 
as homodimers or heterodimers, LRH-1 binds DNA with high affinity as a monomer (Solomon, 
Hager et al. 2005). LRH-1 is known to be involved in the regulation of cholesterol metabolism 
and steroidogenesis in adult mammals (Fayard, Auwerx et al. 2004).  High gonadal expression 
levels of LRH-1 and its ability to regulate the expression of genes involved in steroidogenesis 
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point to a role for LRH-1 in reproductive function (Sirianni, Seely et al. 2002). Indeed, 
depletion of LRH-1 in the ovary disrupts genes required for steroid synthesis and ovulation 
(Duggavathi, Volle et al. 2008). The depletion of LRH-1 in antral follicles allows the formation 
of luteal-like structures, but not functional corpora lutea as evidenced by reduced 
progesterone levels and failure to support pseudopregnancy (Bertolin, Gossen et al. 2014). 
 
 As noted above, recent studies have demonstrated the expression of LRH-1 in murine 
and human uterus in both proliferative and secretory phases of the menstrual cycle (Zhang, 
Large et al. 2013). In order to further study the role of the receptor in the uterus, Zhang et al. 
(2013) created a cKO mouse model using a Cre-LoxP system. Mice with exons 3 and 4 of LRH-
1 flanked by LoxP sites were crossed with mice carrying the Cre recombinase under the 
control of the progesterone receptor promotor, resulting in mice lacking the expression of 
LRH-1 in the tissues expressing  the progesterone receptor (Lydon, DeMayo et al. 1995). 
Although ovulation was not impaired in this cKO model, females remained infertile due to 
the loss of LRH-1 expression in the corpus luteum, resulting in a lower circulating 
progesterone and a failure in implantation. In order to restore the effect of the impaired 
luteinization, mice were supplemented with progesterone by implanting progesterone-
releasing pellets. Progesterone supplementation partially rescued implantation failure, but 
embryos were misplaced, placentation was compromised and gestation failed. To further 
explore the effect of LRH-1 downregulation in the uterus, artificial decidualization was 
induced by injecting oil in the uterus of pseudepregnant females. The decidual reaction failed 
in cKO uteri, suggesting that LRH-1 expression was required for proper decidualization in the 
mouse uterus. Furthermore, in vitro studies using primary culture of human stromal cells 
showed that LRH-1 abrogation using siRNA strategy decreased the expression of decidual 
markers PRL and IGFBP1 and other essential genes for uterine decidualization, such as WNT4, 
which it has shown to be target of LRH-1 (Zhang, Large et al. 2013) (Fig. 2). 
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Fig. 2. LRH-1 in reproduction. LRH-1 is expressed in granulosa cells, where it induces the 
expression of specific target genes related with luteinization and progesterone synthesis. 
LRH-1 is also expressed in the uterus and it is essential for stromal cell differentiation. LRH-1 
activity can be modulated by the binding of different coactivators and corepressors, ligands 
and by post-translational modifications (Brosens, Blanks et al. 2013). 
 
2.5. LRH-1 modulation 
 
 LRH-1, though an orphan nuclear receptor, exhibits constitutive activity (Fayard, 
Auwerx et al. 2004). The constitutive activity of this nuclear receptor can be due to the stable 
conformation of the ligand binding pocket and its association with coactivators. LRH-1 
activity can be also repressed by the recruitment of co-repressors (Fayard, Auwerx et al. 
2004). 
 
 
 
  
29
 
2.5.1. Coactivators/Corepressors 
 
 The small heterodimerization partner (SHP, NR0B2) and dosage-sensitive sex reversal 
adrenal hypoplasia congenital region on the X chromosome, gene1 (DAX-1, NR0B1) are two 
atypical members of the nuclear receptor family that lack a DNA-binding domain. Both are 
co-repressors of LRH-1 activity (Suzuki, Kasahara et al. 2003). Mutations in SHP are associated 
with obesity, as a result of the loss of its repression activity which causes a decrease in 
adipogenesis (Mrosek, Meissburger et al. 2013). SHP is also known to regulate bile acid 
biosynthesis by repressing the expression of cholesterol 7α-hydroxylase (CYP7A1) through 
the inhibition of the transcriptional activity of LRH-1 (Goodwin, Jones et al. 2000). DAX-1 
binds to LRH-1 using a conserved sequence motif, a repressor helix (Sablin, Woods et al. 
2008). LRH-1 and DAX-1 are co-expressed in the ovary, where they regulate production of 
steroid hormones. DAX-1 inhibits LRH-1-mediated transactivation of target genes in the 
corpus luteum (Peng, Kim et al. 2003) and in granulosa cells (Kim, Peng et al. 2004). 
Peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) is another modulator 
of LRH-1 which enhances LRH-1 transcriptional activity (Ondracek and McLachlan 2011). The 
inhibition of PGC-1α suppresses induced LRH-1 activity and inhibits the CYP1 promoter 
activity induced by LRH-1 by up to 80%, providing an important tool for breast cancer therapy   
(Safi, Kovacic et al. 2005). 
 
 
2.5.2. Ligands 
 
 Recent structural studies using the recombinant mouse LRH-1 have identified 
phospholipids as potential in vitro ligands for LRH-1, but their functional relevance is still 
unclear. Although these molecules have been found to bind NR5A2 in vitro, its physiological 
ligand has not been established to date (Krylova, Sablin et al. 2005).  A pharmacological 
compound, dilauroylphosphatidylcholine (DLPC), is a saturated fatty acid and an LRH-1 
agonist ligand in vitro (Lee, Lee et al. 2011). DLPC treatment induces bile acid biosynthesis in 
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mouse, increases bile acid levels and lowers hepatic triglycerides and serum glucose, both 
effects lost in liver-specific LRH-1 KO mouse (Lee, Lee et al. 2011). Insulin-resistant mice 
treated with DLPC show an improved glucose homeostasis, and insulin sensitivity, indicating 
that DLPC might be a promising therapeutic agent for the treatment of diabetes through the 
modulation of LRH-1 activity (Lee, Lee et al. 2011). DLPC is currently in phase 3 clinical trials 
for the treatment of type 2 diabetes in humans (Fig. 3). 
 
 
Fig 3. DLPC regulation of glucose metabolism through the activation of LRH-1 activity. 
(http://www.nature.com/scibx/journal/v4/n23/full/scibx.2011.649.html) 
 
 LRH-1 was shown to regulate expression of the CYP19 gene (Clyne, Speed et al. 2002). 
High levels of LRH-1 expression is correlated with transcriptional activation of CYP19 and its 
expression has been shown to be highly upregulated in breast tumors as well as breast 
adipose tissue surrounding tumors (Zhou, Suzuki et al. 2005). 
 
 In order to provide novel approaches to the treatment of breast cancer, probes that 
can be used as a LRH-1 inverse agonist have been tested using CYP19-luciferase assay to 
examine the effect of this compounds in LRH-1 mediated activation (Busby, Nuhant et al. 
2010). In that study, two of the compounds tested (ML-180 and ML-179) showed up to 60% 
reduction in the CYP19 expression by luciferase assay. Although these probes seem to have 
cytotoxic effects, they might be useful tools for the study of LRH-1 regulation in the drug 
discovery field (Busby, Nuhant et al. 2010). 
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 In all these cases, molecular biology has provided us with a variety of concepts by 
which nuclear receptors and/or their ligands can induce or modulate important physiological 
programs. 
 
2.6. Human infertility 
 
 Human reproduction is an inefficient process, in which only around 30% of conceived 
pregnancies will progress to live birth (Cha, Sun et al. 2012). Clinical infertility is defined as 
the inability to become pregnant after 12 months of unprotected intercourse. It has been 
estimated that between 10–15% of couples have difficulties conceiving (Gurunath, Pandian 
et al. 2011).  
 
 In vitro fertilization (IVF) is one of several assisted reproductive techniques (ART) used 
to help infertile couples to conceive a child, and it is a major treatment of infertility when 
other methods of achieving conception have failed. The process involves hormonally 
controlling the ovulatory process, removing the eggs from the woman's ovaries and letting 
sperm fertilize them in vitro. The fertilized egg is then transferred to the patient’s uterus with 
the intent to establish a successful pregnancy. The first birth of an in vitro-fertilized baby was 
reported in 1978 (Steptoe and Edwards 1978). Since then, over five million pregnancies have 
been achieved worldwide by IVF. 
 
 Although assisted reproductive technologies can be used to overcome infertility 
problems, an accurate diagnosis of the causes of infertility is required in order to choose the 
most efficient technique. The causes of infertility are wide ranging, including ovulatory 
disorders, tubal disease, endometriosis, chromosomal abnormalities, sperm factors and 
unexplained infertility (Healy, Trounson et al. 1994). 
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2.6.1. Implantation failure 
 
 Implantation failure is a common cause of infertility. The causes for repeated 
implantation failure include reduced endometrial receptivity, embryonic defects or 
multifactorial causes (Margalioth, Ben-Chetrit et al. 2006).  In humans, 30% of pregnancy loss 
occurs prior to implantation (preimplantation loss), another 30% is before 6 weeks gestation 
(early pregnancy loss) and 10% prior 12 weeks of gestation (Teklenburg, Salker et al. 2010). 
This high rate of early pregnancy loss is considered to be a strategy for dealing with the high 
prevalence of chromosomal abnormalities in human embryos (Weimar, Kavelaars et al. 
2012). 
 
 Approximately 30% of embryos naturally conceived are lost prior to implantation, and 
50% of IVF embryos fail to implant (Boomsma, Kavelaars et al. 2009). Although our 
knowledge in the mechanisms involved in embryo implantation and interaction with the 
endometrium has increased in recent years, the factors that contribute to this high rate of 
implantation failure still remain unclear. Embryo quality is considered an important cause of 
implantation failure, in IVF patients, embryos are selected before being transferred in order 
to increase the chance of a successful pregnancy (Coughlan, Ledger et al. 2014). 
Preimplantation diagnosis has existed since IVF use began, first with morphological 
observations and then with specific analyses of embryos produced in vitro (Coco 2014).   
 
 Methods of assessment of embryo quality assessment include preimplantation 
screening for specific genetic aberrations, transcriptomic analysis, metabolic analysis and 
time lapse imagining (Duan, Wang et al. 2013).  Even though pre-implantation embryo 
selection may ensure the transfer of a genetically normal embryo, in many cases 
implantation fails, suggesting that the causes for repeated implantation failure may be 
because of reduced endometrial receptivity (Margalioth, Ben-Chetrit et al. 2006). 
Endometrial receptivity is governed by expression of a network of genes that might be used 
as biomarkers for reproductive failure and therapeutic targets for infertility treatment. These 
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genes include prostaglandins, cell adhesion molecules, mucins and cytokines (Koot, 
Teklenburg et al. 2012). Various uterine pathologies, such as thin endometrium, altered 
expression of adhesive molecules and immunological factors, may decrease endometrial 
receptivity (Margalioth, Ben-Chetrit et al. 2006).  
 
 Deregulation of implantation may also be associated with changes immediately prior 
to parturition such as intrauterine growth restriction, misguided embryo placement, ectopic 
placentation, pre-eclampsia, and preterm birth in humans (Cha, Sun et al. 2012) (Fig. 4). 
Improving ART results relies on a better understanding of the pre and peri-conceptional 
cross-talk between the embryo and the uterus and the gene network involved in early 
pregnancy events. 
 
Fig 4. Potential adverse effects of a defective receptivity, implantation and decidualization in 
humans. Implantation failure and decidualization failure might lead to infertility and other  
reproductive defects  (Cha, Sun et al. 2012). 
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2.6.2. Superfertility 
 
 According to retrospective clinical studies, many women suffering from recurrent 
pregnancy loss (RPL), get pregnant very easily, but the embryos are not necessarily healthy 
enough to survive, hence the repeated miscarriages. Consequently these patients report 
short periods between pregnancies and they have higher pregnancy rates compared to 
normal fertile women (Teklenburg, Salker et al. 2010). (Fig. 5). Some 40% of RPL patients 
could be considered as "superfertile", defined as having times between failed pregnancies of 
less than 3 months (Salker, Teklenburg et al. 2010). This new concept of superfertility 
appears related with the enhancement of the endometrial receptivity and the failure to limit 
the window of implantation, allowing embryos of low viability to implant, presenting as a 
clinical pregnancy before miscarrying (Weimar, Kavelaars et al. 2012). The super receptive 
phenotype is also characterized by an abnormal decidualization of the endometrial stromal 
cells (Weimar, Kavelaars et al. 2012). 
 
Fig 5. Embryo wastage iceberg. Pregnancy loss in fertile women and superfertile women. 
Under the blue line, represents pregnancies lost before missing the menstrual period (non 
clinical recognized pregnancy losses). (Teklenburg, Salker et al. 2010) 
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2.7. Cell-embryo co-culture 
 
 The ethical and technical problems to study human implantation in vivo have created 
the necessity to develop in vitro models to investigate embryo-uterine interactions. Embryo-
cell co-culture provides us a good model for understanding the in vivo events of implantation 
and therefore to improve human implantation success. Understanding the molecular 
mechanisms of the interaction between the embryo and the uterine lining is expected to 
provide some clues to further understand the genesis of infertility and the reasons for the 
frequent loss of pregnancy in the peri-implantation period.  
 
 In humans, following fertilization, the egg, termed at that point a zygote, undergoes 
several mitotic divisions. Around day 5 post fertilization, the embryo becomes a blastocyst 
and starts differentiating into two cell populations, the inner cell mass and the 
trophectoderm (Marikawa and Alarcon 2009). The inner cell mass will form the embryo while 
the trophectoderm will form the placenta (Marikawa and Alarcon 2009). At the blastocyst 
stage, embryos hatch from the zona pellucida and gain implantation competency. It is at that 
time when the blastocyst and the uterine endometrium come into an intimate physical and 
physiological contact in order to establish implantation (Bolton and Braude 1987). 
 
 Before implantation, the natural environment to which the embryo is subject is the 
female reproductive tract. Embryos produced using assisted reproductive techniques are 
maintained in culture media from the time of fertilization to the moment they are 
transferred back to the maternal uterus. Much speculation about epigenetic modifications 
caused by media and culture conditions have caused questioning of whether embryo quality 
can be improved in vitro by co-culturing them with autologous cells from patients (Simon, 
Mercader et al. 1999).   
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 Multiple cell types have been used in co-culture systems, endometrial cells, oviductal 
cells, (Bongso, Fong et al. 1994), Fallopian tubal cells (Bongso, Ng et al. 1992), cumulus and 
granulosa cells (Dirnfeld, Goldman et al. 1997), not only to study the mechanisms of embryo 
development and implantation but also to improve embryo quality and consequently 
pregnancy rates in IVF patients.  
 
2.7.1. Stromal cells: Biosensor for embryo quality 
 
 It is known that embryos suffering from aneuploidies have a lower developmental and 
implantation potential (Rubio, Pehlivan et al. 2005), but whether the cause if the 
implantation failure lies with the embryo or endometrial factors is an unsolved question. 
Although poor embryo quality is considered to be the major cause of implantation failure, 
there is new emerging evidence suggesting that decidualized endometrial stromal cells are 
biological sensors capable to selectively recognize poor quality embryos (Weimar, Kavelaars 
et al. 2012). Recent studies comparing recurrent miscarriage (RM) patients and normal fertile 
women have demonstrated that the migratory activity of hESC from women suffering from 
recurrent miscarriages is impaired, being less efficient to discriminate between low and high 
quality embryos compared to cells from normal fertile women (Weimar, Kavelaars et al. 
2012). Defects in the decidual process might lead in a failure of the endometrium to become 
receptive. Moreover, decidualized endometrial stromal cells appear to play an active role in 
the embryo implantation, demonstrating motility towards the embryo at the implantation 
site, in a process regulated by Rho GTPases (Grewal, Carver et al. 2008) (Fig. 6). 
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Fig 6. Migration activity of hESC from women suffering from RM and normal fertile women in 
co-culture with low quality embryos and high quality embryos. (Weimar, Kavelaars et al. 
2012) 
 
 Based on the previous work in our laboratory showing that LRH-1 is essential for 
appropriate mouse decidualization and our preliminary work with human endometrial cells 
in primary culture, we chose to further explore the phenomenon of decidualization in an 
immortalized endometrial stromal cell line (hESC).  This cell line displays characteristics of 
human decidualization (Krikun, Mor et al. 2004).  Our experiments took the form of 
characterization of LRH-1 expression during in vitro differentiation, and short hairpin RNA 
(shRNA), pharmacological manipulation of the activity of this orphan nuclear receptor, and 
exploration of co-culture of the hESC cells with murine embryos.  
 
 So our hypothesis is that LRH-1 regulates human decidualization. Our goal is to define 
the Lrh-1 transcriptional network regulating reprogramming of stromal cells into decidual 
cells by characterizing the gene expression pattern during decidual fibroblast differentiation. 
Moreover we want to asses the effect of LRH-1 abrogation on cell migration towards an 
embryo. 
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3. Materials and methods 
 
3.1. Cell line 
 
 All experiments were undertaken using a fibroblast human telomerase (h-Tert) 
immortalized endometrial stromal cell line from ATCC (ATCC® CRL-4003) (Virginia, US). 
The cell line was derived from stromal cells obtained from an adult woman and cells were 
immortalized by infection with supernatant from the packaging cell line pA317-hTERT which 
expressed the hTERT and the puromycin resistance genes (Krikun, Mor et al. 2004). 
The cell line is diploid and the karyotype is stable (46 chromosomes) in 57% of the examined 
cells and presented a low rate of polyploidy. No consistent structural chromosomal 
aberrations were found in any of the cells examined, according to the supplier.  
 
3.1.1. Cell culture media and decidualization media 
 
 Cells were maintained in a mixture of Dulbecco's modified Eagle's medium and Ham's 
F-12 medium (DMEM/F12) with g/L glucose and no phenol red from Sigma (St. Louis, 
Missouri). Medium was supplemented with 10% charcoal stripped foetal bovine serum 
(Invitrogen, Carlsbad, CA, USA), 5 μg/ml insulin (Sigma), 5 ng/ml sodium selenite (Sigma), 100 
u/100 μg/ml penicillin/streptomycin (Invitrogen), and 0.25 μg/ml fungizone (Gibco,St. Louis, 
Missouri). The medium was replaced every 2 to 3 days with fresh media. Cells were 
decidualized in vitro by supplementing the medium with a mixture of 1 μM 
medroxyprogesterone acetate (MPA) (Sigma) and 0.5 mM 8-Br-c-AMP (Sigma) over 9 days 
according to the procedure described by (Krikun, Mor et al. 2004). 
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3.2. Plasmids and transfections 
 
 Five shRNA constructs against LRH-1 were purchased from Invitrogen (Carlsbad, CA, 
USA)(sequences included in the Table 1). The plasmid (Plasmid 16342: pHA-mLRH-1)used for 
the overexpression experiments was purchased from Addgene (Cambridge, Massachusetts, 
USA).Lrh-1 knock down and overexpression cell models were generated by transfection using 
Lipofectamine 2000 (Life technologies, St. Louis, Missouri).   
 
Table 1. LRH-1 shRNA sequences employed to manipulate LRH-1 expression in hESC. 
 
LRH-1 
shRNA 
Reference 
number 
Backbone 
plasmid 
Sequence 
1 TRCN0000349
608 pLKO.1 
CCGGGCGTTGTCCTTACTGTCGTTTCTCGAGAAACG
ACAGTAAGGACAACGCTTTTTG 
2 TRCN0000019
654 pLKO.1 
CCGGCCGAGTCCATAATGGGCTATTCTCGAGAATAG
CCCATTATGGACTCGGTTTTT 
3 TRCN0000019
655 pLKO.1 
CCGGGCTCTTTAGTTTAGATGTCAACTCGAGTTGAC
ATCTAAACTAAAGAGCTTTTT 
4 TRCN0000019
656 pLKO.1 
CCGGGCGTTGTCCTTACTGTCGTTTCTCGAGAAACG
ACAGTAAGGACAACGCTTTTT 
5 TRCN0000019
657 pLKO.1 
CCGGGCTGGACTACACAATGTGTAACTCGAGTTACA
CATTGTGTAGTCCAGCTTTTT 
 
3.3. RNA extraction and purification 
 
 Cells were collected and RNA was extracted and purified using RNeasy Micro Kit 
(Qiagen (Hilden, Germany) using manufacturer's instructions. RNA samples were quantified 
using a Nanodropspectrophotometer (Nanodrop Technologies, Wilmington, DE). RNA  
extracted was submitted to DNase treatment and retrotranscribed using SuperScript III (Life 
Technologies).   
 
3.4. Quantitative polymerase chain reaction analysis (qPCR) 
 
 The consequent cDNA samples (500 ng cDNA) were used to perform qPCR using 7300 
real-time PCR system (Applied Biosystems, Foster City. CA). The thermal cycling program was: 
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2 min at 50ºC, 10 min at 95ºC, 40 cycles of 15 s at 95ºC and 60 s at 60ºC. Samples were run in 
triplicate, each replicate containing 10 μL Power SYBR® Green PCR Master Mix (Applied 
Bioscience, Warrington, UK), 4 μL of sense-antisense primer mix and 6 μL cDNA sample (1/15 
dilution). All primers were tested using melting curve analysis to verify product identity, 
adding a dissociation step to the PCR run (15 s at 95ºC, 60 min at 60ºC, 15 s at 95ºC and 15 s 
at 60ºC). Primer information and sequences are listed in Table 2. Expression data were 
analysed and normalized to the endogenous reference gene glyceraldehyde 3-phosphate 
dehydrogenase(GAPDH) and relative abundance of transcripts were calculated using the 
ΔΔCt method corrected by the efficiency of amplification, as described by Pfaffl (Pfaffl 2001).   
 
Table2. Primer sequences used 
Gene Exons Forward primer Reverse primer 
NR5A2 3-4 GGGTACCATTATGGGCTCCT TGTCAATTTGGCAGTTCTGG 
IGFBP1 2-3 TATGATGGCTCGAAGGCTCT CCTGTGCCTTGGCTAAACTC 
PRL 1-2 AAGTGTGTTTCCTGCAACGA CACAGGAGCAGGTTTGACAC 
GAPDH 1-2 GAAGGTGAAGGTCGGAGTC GAAGATGGTGATGGGATTTC 
 
3.5. Western Blot analysis 
 
 Proteins were collected using M-Per mammalian protein extraction reagent (Thermo 
Scientific, Waltham, MA,) and quantified using the Bradford assay (Kruger 1994). 
An aliquot of 30 μg of total protein was loaded from each sample in a 10% sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel and transferred to a 
polyvinylidenedifluoride (PVDF) membrane (GE Healthcare, Little Chalfont, United Kingdom). 
The membrane was blocked using 5% nonfat milk in Tris buffered saline containing 0.1 % 
Triton (TBST) (Sigma, St. Louis, Missouri) for an hour at room temperature, incubated with 
rabbit polyclonal Nr5a2 (ab 18293, Abcam, Cambridge, UK) diluted 1:500 and 1:250 human 
influenza hemagglutinin (HA) antibody in TBST overnight at 4ºC. Membranes were then 
incubated in horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (Santa Cruz 
Biotechnology, Dallas, Texas) diluted 1:50.000 in blocking solution for 30 min at room 
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temperature. Proteins were visualized by chemiluminescence (Immobilon Western, Millipore 
Corporation, Billerica, MA) for the overexpression model and using BioradChemidoc MP 
Imaging system for the knock down model. Subsequently, membranes were washed, blocked 
as above, and incubated with HRP conjugated antimouse β-actin (Santa Cruz Biotechnology) 
diluted 1:80.000 in TBST for 30 min at room temperature. The optical density bands were 
detected at the expected molecular weight for LRH-1, Influenza hemagglutinin (HA) protein 
and β-actin (constitutive control) were quantified by the Image Processing and Analysis Java 
(ImageJ) software for the overexpression model and Image lab software from Biorad for the 
knock down model. The ratio of density between LRH-1 and β-actin was calculated for each 
sample. 
 
3.6. Immunofluorescence 
 
 LRH-1 expression was evaluated in cells by immunofluorescence. Cells were grown on 
coverslips and fixed using 4% paraformaldehyde (PAF) for 20 min. Coverslips were then 
washed using phosphate buffered saline (PBS), washed for 5 min with PBS + 20% Triton, 
washed for 3 times 5 min with PBS + 5% Tween and then blocked for 1 h in BSA 5%. 
Coverslips were incubated overnight with rabbit polyclonal LRH1 (Abcam, ab 18293) diluted 
1:75.  On the following day, coverslips were washed with PBS and incubated with the second 
antibody, goat antirabbit conjugated to CY3 (Jackson immunoresearch, West Grove, PA, USA) 
diluted 1:300 for 1 h, washed with PBS and then incubated for 5 min with DAPI (4 ',6-
diamino-2-phenylindole, Sigma) diluted 1:1000. Coverslips were mounted using Permafluor 
(Lab Vision Corp., Fremont, CA). Pictures were taken using the microscope Zeiss Palm 
Microbeam. 
 
3.7. Phalloidin staining 
 
 Cells were grown on coverslips and fixed using 4% PAF for 20 min. Coverslips were 
then washed using PBS, washed for 5 min with PBS + 20%Triton, washed for 3 times 5 min 
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with PBS + 5% Tween and then blocked for 1h in bovine serum albumin (BSA) 5%. Coverslips 
were incubated for 20 min with phalloidin (Invitrogen, Carlsbad, CA, USA) diluted 1:20. 
Coverslips were washed with PBS and incubated for 5 min with DAPI (diluted 1:1000). 
Coverslips were mounted using Permafluor. Pictures were taken using the microscope Zeiss 
Palm Microbeam. 
 
3.8. Chromatin Immunoprecipitation (chIP) 
 Chromatin immunoprecipitation is a technique widely used to study protein-DNA 
interactions that are essential for transcriptional regulation. The chIP for LRH-1 using hESC 
was performed according to the method described by (Svotelis, Gevry et al. 2009) and is 
described in brief below.   
 
3.8.1 Cell crosslinking 
 Cells were grown in T-150 flasks. Medium was removed and cells washed with PBS + 
proteinase inhibitors cocktail (aprotinin, bestatin, calpain inhibitor I, calpain inhibitor II. 
chymostatin, E-64, leupeptin, α2-macroglobulin, pefabloc SC, pepstatin, 
phenylmethanesulfonylfluoride(PMSF), TLCK-HCL, trypsin Inhibitor all from Roche (Basel, 
Switzerland). Protein and DNA were crosslinked by adding 20 µl of 1.1% PBS-formaldehyde 
for 10 min at room temperature.  An amount of 10 µl of a concentration 2.5 M glycine/PBS 
was added to stop the crosslinking reaction for 5 min. Cells were then washed with cold PBS 
and 2 ml Buffer A (100mM Tris-HCl, 1nM PMSF, 10 nM DDT, protease inhibitor cocktail) was 
added. Cells were collected by scraping and incubated for 20 min at 30ºC and then 
centrifuged at 4ºC. The pellet obtained was snap frozen in liquid nitrogen and kept at -80ºC 
until analysis was undertaken.  
 
3.8.2. Cell lysis 
 Cell pellets were lysed by incubating for 30 min at 4 ºC in lysis buffer (20% sodium 
dodecyl sulfate(SDS), 0.5M Ethylenediaminetetraacetic acid (EDTA), 1M Tris). 
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Immunoprecipitation dilution buffer (0.01% SDS, 1.1 % Triton, 1.2 mM EDTA, 16.7 mM Tris of 
pH 8.1, 167 mM NaCl) was then added to complete the volume. 
 
3.8.3. Sonication 
 Cells were sonicated to obtain 100 -500 base pair (bp) DNA fragments: 5 cycles of 10 
seconds with 3 min intervals between each.  Samples were then centrifuged at 13,000 
revolutions per minute (rpm) for 12 min at 4 ºC and DNA sonication efficiency was tested by 
migrating samples on a 1.2% agarose gel and comparing with DNA ladder standards (NEB 100 
bp DNA Ladder, UK) 
 
 Antibodies for LRH-1 (monoclonal 1mg/mL R&D Systems, Minneapolis, MN), RNA 
polymerase (RNA Pol II 8WG16 Covance MMS-126R), no antibody buffer control were 
incubated overnight with the samples . 
 
3.8.4. Magnetic bead preparation 
 Protein A beads (Sigma 1002D) were used to immunoprecipitate the samples. Beads 
were washed 3 times at 4ºC using immunoprecipitation buffer + PMSF and a magnetic 
separator (Promega Magnetic Support). Once washed, beads were added to the samples and 
incubated in agitation at 4ºC for 2 hours.  
 
3.8.5. Washes 
 Samples were washed at room temperature using cHIP buffers: 
TSE-150 (0.1 % SDS, 1% Triton, 2mM EDTA, 20 mM Tris-HCl of PH 8.1, 150 mM NaCl) 1 wash 
for 5 min. TSE-500 (0.1 % SDS, 1% Triton, 2mM EDTA, 20 mM Tris-HCl of PH 8.1, 500 mM 
NaCl) 1 wash for 5 min. Li Cl detergent ( 0.25 M LiCl, 1% NP40, 1% sodium deoxycholate, 
1mM EDTA, 10mM Tris of PH 8.1) 1 wash for 5 min. TE (10 mM Tris of pH 8.0, 1 mM EDTA) 3 
washes for 5 min.  
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3.8.6. Elution 
 After the washes, supernatant was removed and elution buffer (20% SDS, 0.25M 
NaHCO3, Sigma) was added. Samples were incubated for 45 min at 65ºC in agitation. 
Magnetic beads were then removed using the magnetic support and supernatant was 
incubated overnight at 65ºC. 
 
3.8.7. DNA purification 
 In order to eliminate any endogenous RNA, samples were treated with 10 µg/µL 
RNAase (Bioshop, Burlington, Ontario) for  30 min at 37 ºC and then treated with 20 µg/µL 
proteinase K (Bioshop, Burlington, Ontario) for 2 h at 37 ºC. 
 
 DNA was purified using Qiagen kit (MiniElute® PCR Purification Kit cat. n. 28004) and 
PCR analyses were performed for the target genes as described above . 
 
3.9. hESC-embryo co-culture 
 
 Superstimulation of immature (22 to 24 day old) C57B6/B6129 females was achieved 
by injection with  equine chorionic gonadotropin (5 IU i.p.) and human chorionic 
gonadotropin (hCG; 5IU i.p.) to stimulate the growth and recruitment of ovarian follicles and 
to induce ovulation, respectively.  There was a 44 to 48 h of interval between each injection 
and then mice were mated with fertile males. Mice were anesthetised with isofluorane (USP, 
Pr AErran, Baxter corporation, Mississauga, ON, Canada) and euthanasia was achieved by 
cervical dislocation. Uteri from 3.5 day pregnant mice were flushed using M2 media (Sigma, 
St. Louis, Missouri) and embryos were cultured in KSOM media (95 mM NaCl, 2.5 mM KCl, 
0,35 mM KH2PO4, 0,20 mM MgSO4-7H2O, 25mM NaHCO3, 1,71 mM CaCl2-2H2O, 0,20 mM D-
glucose, 10 mM Sodium Lactate, 0,20 mM Sodium pyruvate, 0,01 mM EDTA, 1 mM L-
glutamine, 1,0 g/L BSA, 100 U/ml Sodium penicillin G, 0,05 g/L Streptomycin without 
NaH2PO4-H2O, Phenol Red or HEPES) for 24 h. After 24 h, blastocysts were co-cultured with 
confluent hESC cells that had been decidualized over 9 days according to the protocol 
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described above. Cell- embryo co-culture was maintained for 2 days and a wound in the cell 
monolayer was created in order to perform a wound healing assay as described by 
(Rodriguez, Wu et al. 2005). Pictures from the wound healing assay were taken using  a Nikon 
eclipse TS100 dissecting microscope. 
 
3.10. Statistical analysis: 
 
 All data were analysed using JMP (version 5.0.1.a. SAS Institute Inc.) statistical 
software. Differences between decidualized and non decidualized gene expression for single 
point data were determine by Student's t-test. For data obtained at multiple time points or 
multiples genotypes (wild type and overexpression) two-way analyses of variance (ANOVA) 
and differences between individual means were determined by JMP LS-Means Constrast test.  
All numerical data are represented as mean ± SE (standard error). The level of statistical 
significance was set at P<0.05. 
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4. Results 
 
LRH-1 is expressed in hESC and its expression increases during in vitro decidualization 
 
 To study the effect of LRH-1 expression in the decidualization process, we established 
an in vitro model using a human endometrial stromal cell line. In vitro decidualization can be 
achieved by treating the cells for 9 days with cAMP and MPA. We previously demonstrated 
that LRH-1 is expressed in mice and human uteri in both proliferative and secretory phases 
(Bai, Gao et al. 2013) and Western blot analyses revealed that LRH-1 is expressed in hESC 
(Fig.7A). Decidualization is a form of differentiation that transforms precursor stromal cells 
that can be characterized by changes in the cell morphology and gene expression. 
Decidualization requires the reorganization of the actin cytoskeleton (Ihnatovych, Livak et al. 
2009). Comparison of MPA/cAMP treated cells and non-treated cells at 9 days after the 
initiation of treatment demonstrates that this reorganization, as shown by 
immunofluorescent staining of phalloidin,can be also observed in hESC (Fig.7B). Moreover, 
measurement of the RNA abundance of biochemical markers for decidualization, insulin-like 
growth factor-binding protein 1 (IGFBP1) and prolactin (PRL), revealed that the expression of 
these two marker genes increased during in vitro decidualization, together with an increase 
in the expression of LRH-1(Fig.7C). Immunocytochemical observations also indicated 
apparent increases in the signal for nuclear LRH-1 in decidualized hESC treated for 9 days 
with cAMP and MPA compared to the nondecidualized cells (Fig.7D). 
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LRH-1 binding sites for target genes are enriched in decidualized cells 
 
 LRH-1 regulation of gene expression occurs by binding of the receptor to the 
regulatory regions of target genes (Chong, Biesinger et al. 2012).  To identify direct genomic 
targets of LRH-1 during the decidual process, we performed a chromatin 
immunoprecipitation assay. Proteins and DNA from hESC were crosslinked and chromatin 
was sonicated to shear DNA (Fig. 8A) which was then precipitated using a specific antibody 
for LRH-1.  Quantification of the DNA bound to LRH-1 by PCR (Fig.8B) showed that 
decidualization induced recruitment of RNA polymerase II (RNAPol II) which is a mark of 
transcriptional activity and a critical rate-limiting step for gene regulation of transcriptional 
factors (Orphanides, Lagrange et al. 1996).  The ChIP assay (Fig. 8B) revealed there was 
enrichment of LRH-1 binding to regulatory regions of a WNT4, WNT5, IL21, PRL, CYP19, and 
the cell cycle inhibitor CDKN1A (p21)  in hESC prior to decidualization.   There was further 
enrichment at a distal site for CDKN1A.  Figure 8B further demonstrates that the LRH-1 
binding was more abundant in each of these genes following the incubation with the 
decidualizing factors, MPA and cAMP. 
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The overexpression of LRH-1 in hESc results in a precocious decidualization 
 
 To investigate the effect of LRH-1 expression in decidualization, we created an 
overexpressing hESC line by transfecting the cells with a plasmid constitutively expressing 
LRH-1 fused with the human influenza hemagglutinin tag (HA-LRH-1).  As a control, cells were 
transfected with an empty plasmid. Plasmid incorporation was evaluated by Western blot 
analysis, the presence of the HA tag was confirmed by the detection of the HA tag using an 
anti-HA antibody.  Success of transfection was confirmed by immunoblot analysis (Fig. 9A) 
clearly demonstrating both LRH-1 overexpression and the occurrence of HA protein in hESC  
transfected with HA-LRH-1. To compare the effects on gene expression, both overexpressing 
cells and control cells were decidualized in vitro. RNA was collected before and after 
decidualization to explore the abundance of transcripts of decidualization marker genes, by  
qPCR analysis. LRH-1 transcript was more abundant in overexpressing cells before 
decidualization and four fold higher than in contemporary decidualized hESC (Fig 9B).  The 
relative abundance of both PRL and IGFBP1 was markedly increased in cells overexpressing 
LRH-1 compared to the control, moreover, overexpressing cells showed a greater increase in 
decidualization marker genes after in vitro decidualization (Fig.9B). 
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LRH-1 activity can be modulated by using synthetic ligands in vitro 
 
 To demonstrate the potential of LRH-1 as a target gene for the treatment of infertility 
in human, hESC were treated using two different ligands in vitro. Cells were treated  over 12 
h with 100 μM LRH-1 agonist DLPC and 6 days with 10 μM LRH-1 ML-180 inverse agonist. 
Real-time PCR assays were developed for RNA quantification analysis of the decidual marker 
genes PRL and IGFBP1. DLPC caused small induction of PRL and IGFBP1  in treated hESC (Fig. 
10A) although only IGFBP1 expression in cells treated for 8 h was significantly different 
compared to the non treated control. ML-180 treatment  slightly reduced the abundance of 
PRL and IGFBP1 transcripts (Fig. 10B) but only IGFBP1 expression in cells treated for 6 days 
was significantly different compared to the control. These results suggested that DLPC and 
ML-180 might modulate expression of LRH-1 target genes in hESC, although the doses and 
exposure time will have to be optimized.  
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LRH-1 knock down in hESC abrogates cell motility response towards the embryo 
 
 To determine whether normal decidualized hESC and LRH-1 gene knock down hESC 
(kd hESC) in culture migrate differently in the presence of an embryo, we analyzed the hESC 
migratory response using a co-culture system in which the cells were cultured for 2 days in 
the presence of a day 3.5 mouse embryo. Four different shRNA constructs against LRH-1 
were tested and the most efficient construct was used to knock down endogenous gene 
expression. Western blot analysis confirmed the selective downregulation of LRH-1 in sh-
LRH-1-transfected cells (Fig. 11A). The effect of the presence of an embryo on stromal cell 
migration characteristics of decidualized hESC and Kd hESC was evaluated by a cell migration 
assay using scratch wound healing. While hESC were able to adjust their migratory activity in 
response to the embryo, LRH-1 knock down reduced the intensity of the migration 
phenotype observed in wild type cells. Lrh-1-ablated cells show impaired migration, leading 
to a failure of the embryo to attach (Fig. 11B). 
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5. Discussion 
 
Characterization of in vitro decidualization 
 Decidualization is a process of differentiation of the uterus to a receptive state 
essential for a successful crosstalk between the embryo and the endometrium and thus, the 
establishment of gestation (Das 2009). LRH-1 has been demonstrated to be expressed in both 
the mouse and human endometrium during decidualization (Zhang, Large et al. 2013). 
Moreover, depletion of LRH-1 abrogates expression of several genes known to be 
indispensable for uterine stromal decidualization and placenta formation, including those 
explored in this study, PRL and IGFBP-1 (Zhang, Large et al. 2013). 
 
 The use of in vitro cellular models has allowed greater insight into the mechanisms 
controlling cellular signalling actions and molecular events. In the current study, we 
established an in vitro model of decidualization using immortalized hESC (Krikun, Mor et al. 
2004) which displayed the morphological pattern and biochemical endpoints of 
decidualization including IGFBP-1 and PRL after treatment with MPA and cAMP.  The hESC 
cell line was examined for the presence of LRH-1 and we showed that expression augmented 
with differentiation. Decidualization is also characterized by a dramatic increase in 
filamentous actin polymerization and stress fiber formation reorganization of the actin 
cytoskeleton. It has been shown that the disruption of actin filaments by cytochalasin D leads 
to a significant enhancement of decidualization in vitro (Kim, Jaffe et al. 1999).  Furthermore, 
upregulation of myosin light chain (MLC) phosphorylation , which stimulates myosin II 
activity, prevents in vitro decidualization of human stromal fibroblasts (Ihnatovych, Hu et al. 
2007).  Our analysis of cell morphology using staining of filamentous-actin in undifferentiated 
endometrial stromal cells and cells decidualized in vitro demonstrated the reorganization in 
the actin cytoskeleton of the cells after in vitro decidualization. Together these results 
provide credible evidence to indicate that decidualization in hESC cells phenocopies much of 
the process of human decidualization in vivo.  
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Identification of LRH-1 target genes in hESC 
 Previous reports investigating the role of LRH-1 in breast cancer cell line, MCF7, have 
identified LRH-1 target genes across the genome using Formaldehyde-Assisted Isolation of 
Regulatory Elements (FAIRE-seq) and ChIP-seq methods (Bianco, Brunelle et al. 2014). 
Stromal cell transformation into decidual cells is a highly controlled event and is likely to 
involve a network of genes. To further understand the mechanism of LRH-1 regulation of 
decidualization, we performed ChIP on differentiated and undifferentiated hESC followed by 
quantitative PCR to assay for some known LRH-1 target genes. ChIP analysis demonstrated 
that LRH-1 binds specific regions of DNA and interacts to drive the expression of a genes 
related with the decidual process such as WNT5, WNT4, Il-24, PRL, CYP19 and CDKN1A. The 
non-canonical Wnt pathway has been suggested to play an important role in uterine function 
(Lee, Jeong et al. 2007), and attenuation of WNT4 expression in hESCs by small interfering 
RNA greatly reduces stromal differentiation (Inlay, Choe et al. 2013). Additionally, 
adenovirus-mediated overexpression of WNT4 in hESCs markedly advanced the 
differentiation program, indicating that it is a key regulator of decidualization (Li, Kannan et 
al. 2013). WNT5a expression is localized at the M pole prior to and following implantation 
(Cha, Bartos et al. 2014). Moreover, Wnt5a depletion by tissue-specific knockdown in mice 
results in defective implantation and decidual growth restriction (Cha, Bartos et al. 2014), 
indicating the importance of this gene in the decidual process.  
 
 Decidualization engenders both differentiation and apoptosis of stromal cells, 
decidual cell death is considered the end point of timed differentiation (Akcali, Gibori et al. 
2003). We therefore explored factors that are associated with processes of differentiation in 
the hESC line. The cytokine IL-24 is known to play a role in decidualization by suppressing the 
viability of decidual cells by promoting apoptosis through binding the receptors IL-20R2/IL-
22RI (Shao, Li et al. 2013). In addition, IL-24 produced at the maternal-fetal interface in 
human first trimester pregnancy is necessary for the invasion of trophoblast and is therefore 
  
58
 
an element involved in normal pregnancy (Cheng and Zou 2008).  Our results demonstrate 
enrichment of LRH-1 sites on the IL-24 gene, implicating LRH-1 in its regulation.  Of the other 
genes that we tested, CDKN1A, is an important regulator of cell cycle progression at G1. 
There is evidence that the expression of CDKN1A during development strongly correlates 
with the process of terminal differentiation in mammalian cells (Parker, Eichele et al. 1995).  
Published information indicates that CDKN1A is expressed in the afternoon of day 5 dpc in 
mouse stromal cells immediately surrounding the blastocyst and it downregulates cyclin 
D3/cdk4, promoting differentiation to form the primary decidual zone (Tan, Raja et al. 2002).  
As above, our ChIP analysis identified CDKN1A as target for LRH-1 and thus potentially 
regulation by the orphan receptor during decidualization.  
 
 Decidualization is also regulated by endocrine and paracrine factors, and we were 
interested in which of these are present in decidual cells and potentially regulated by LRH-1.  
PRL and its receptor are both markedly induced in the human endometrial stroma during 
decidualization, and abundant PRL is released by decidual cells as differentiation progresses 
(Eyal, Jomain et al. 2007).  Locally produced PRL acts in an autocrine manner and is known to 
play a dual role, first by limiting the extent of differentiation of decidual cells and, secondly 
by preparing the uterus for embryo implantation (Eyal, Jomain et al. 2007).  The enrichment  
that we showed in LRH-1 binding sites in the PRL gene during decidualization of hESC 
confirms that this important factor in decidualization is an LRH-1 target.  It is well known that 
the sex steroid hormones, estrogen and progesterone, via their receptors, play critical roles 
in uterine receptivity, implantation, and decidualization (Evans 1988).  There is good 
evidence for local synthesis of estrogens, as P450 aromatase (CYP19), the enzyme catalysing 
the conversion of androgens into oestrogens is present in human endometrial stroma (Bulun, 
Economos et al. 1994). LRH-1 plays an important role as a factor in regulating CYP19 
promoter and thus estrogen biosynthesis, in the ovary (Hinshelwood, Repa et al. 2003). ChIP 
analysis provides evidence to indicate that LRH-1 can regulate the expression of CYP19 in the 
uterus, thus potentially controlling the local production of estrogen during the early 
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pregnancy that is not only required for implantation, but also for the decidualization 
program.  
LRH-1 overexpression model 
 LRH-1 depletion by RNA interference in primary culture of human endometrial 
stromal cells decreases the abundance of decidual markers PRL and IGFBP1 (Zhang, Li et al. 
2013). To explore this phenomenon in hESC cells, we overexpressed LRH-1 by transfection of 
a plasmid construct to induce its constitutive overexpression.  The results were of 
considerable interest, in that they further supported the concept of LRH-1 as a potent 
regulator of the decidualization process.  This was demonstrated by the augmentation in 
abundance of decidual markers, IGFBP1 and PRL in undifferentiated cells in a pattern similar 
to that induced by decidualization.  Overexpression of LRH-1 in differentiated cells led to a 
more pronounced increase in IGFBP1 and PRL transcripts and a precocious development of 
the decidual reaction.  The results obtained by overexpression further strengthen the case 
for LRH-1 as a key regulator of the human endometrial stromal cell differentiation that is 
essential for successful gestation.  
 
LRH-1 modulation through the use of ligands 
 Nuclear receptors are transcriptional factors that regulate many biological processes 
and diseases.  Nuclear receptor agonists and antagonists such as tamoxifen or 
thiazolidinediones are among the most commonly used drugs, the former acting on estrogen 
receptors, the latter on PPARs  (Gronemeyer, Gustafsson et al. 2004).   Although the LRH-1 
receptor contains a classic ligand pocket that accommodates some naturally occurring 
sphingolipids (Urs, Dammer et al. 2007), the endogenous ligand(s) remain undiscovered.  The 
regulation of LRH-1 action is further complicated by its constitutive activity (Burendahl, 
Treuter et al. 2008) and regulation by inhibitory cofactors such as the orphan nuclear 
receptors that lack DNA binding domains, short heterodimeric protein-1 (SHP) (Volle, 
Duggavathi et al. 2007) and dosage-sensitive sex-reversal adrenal hypoplasia congenital 
critical region on the X chromosome gene  (DAX-1) (Sablin, Woods et al. 2008).  These 
elements of regulation have been exploited in the design of pharmacological modulators of 
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LRH-1 activity.  DLPC binds to LRH-1, causing stearic changes in LRH-1 and interfering with the 
interactions with SHP and DAX-1, abrogating inhibition and thus functioning as an agonist to 
induce LRH-1 transcriptional activity (Musille, Pathak et al. 2012). Our results showed that 
cells treated with DLPC for 8 h had significantly increased the expression of decidualization 
marker gene IGFBP1.  We further explored the compound ML-180 (cis-bicyclo[3.3.0]-oct-2-
ene) that functions as an LRH-1 reverse agonist (Busby et al. 2011).  Its mechanism is not yet 
known, but it is believed to affect the receptor occupancy of promoters of LHR-1 target genes 
(Busby, Nuhant et al. 2010). ML-180 treatments significantly reduced the abundance of 
IGFBP1 transcripts. Taken together, these data show that it is possible to modulate of LRH-1 
activity through the use of specific pharmacological agents.  This finding will allow the 
development of novel strategies of nuclear receptor therapy for the treatment of 
reproductive diseases. Further experiments using different concentrations and exposition 
times are needed to elucidate the dose-dependent action and determine whether there are 
any side effects of these drugs for use for human therapy. 
 
hESC-embryo co-culture and migration assay 
 Recurrent pregnancy loss affects 1-2% of couples and is defined as three or more 
consecutive miscarriages (Rai and Regan 2006). Broadly speaking, the most common cause is 
chromosomal abnormalities of the embryo. It has been estimated that one in three of all 
implanting embryos is lost before six weeks of pregnancy (Urman, Yakin et al. 2005).  In 
addition, more than 10% of more advanced pregnancies end in miscarriage (Simon, Rubio et 
al. 1998). Miscarriage can be caused not only by chromosomal abnormalities in the embryo 
but also by defects in uterine environment (Rai and Regan 2006). Recent published studies 
from Brosens and colleagues (Salker, Teklenburg et al. 2010) have established that the lining 
of the womb is capable of recognising and responding to abnormal embryos but only when is 
adequately decidualized.  Moreover, the ability of the lining of the womb to decidualize is 
known to be defective in women suffering from recurrent miscarriages. Combined, these 
observations indicate that impaired decidualization and lack of embryo quality control at the 
time of implantation may be a primary cause of miscarriage. Therefore the failure of the 
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endometrial stromal cells to undergo an appropriate decidualization can lead not only to late 
implantation of poorer quality embryos but also to early placental failure, regardless of 
embryonic karyotype. Decidualized stromal cells appear to display direct motility towards the 
embryo at the time of implantation (Grewal, Carver et al. 2008). Autologous endometrial co-
culture creates a more physiological environment for embryonic development and has been 
used successfully in clinical IVF to improve embryo quality in poor prognosis patients 
(Birkenfeld and Navot 1991). LRH-1 overexpression in MCF7 cells promotes the remodelling 
of the actin cytoskeleton and increases cell migration (Chand, Herridge et al. 2010), 
suggesting it may be an important factor in the process of migration of decidualized stromal 
cells toward an embryo.   
 
 To test whether our hESC demonstrate migratory activity toward an embryo, we 
establish an in vitro co-culture model using hESC and 3.5 day mice embryos where a 
migration zone was created.  After two days of co-culture, cells showed a migration towards 
the hatched embryo, by actively orienting their actin cytoskeleton toward the position where 
the embryo was placed. To analyse the function of LRH-1 in stromal epithelial cells, 
endogenous LRH-1 expression was knocked down in the hESC cell line using shRNA. LRH-1 
knockdown significantly impaired the ability of hESC cells to migrate into the wound where 
the embryo was placed. In addition, the embryo co-cultured with LRH-1 knock down hESC 
failed to hatch and attach to the cells suggesting that LRH-1 expression is essential for the 
embryo–uterine cross-talk during early implantation. 
 
 The sum of our results using multiple methods and endpoints argue strongly for the 
conclusion that intrinsic failure of endometrial stromal cells to mount an appropriate 
decidual response might be due to the lack of LRH-1. This orphan nuclear receptor is most 
likely controlling the expression of a set of genes important for a successful decidualization. 
Indeed, we here provide evidence that LRH-1 is a key regulator of the complex transcriptional 
network involved in the dramatic reprogramming of endometrial stromal cells during 
decidualization. We have also showed here that the systemic delivery of sequence-specific 
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shRNA against the LRH-1 gene product dramatically inhibits cell migration in the presence of 
an embryo. Our observations, therefore, not only confirm an important role of LRH-1 in 
human decidualization, but also provide insight into a novel function of the receptor in 
controlling hESC migration in vitro.  
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6. Conclusion 
 
In summary, we have further demonstrated that LRH-1 is essential for human decidualization 
using a hESCs in vitro model. Using chIP technique we have demonstrated that LRH-1 
regulates distinct sets of target genes during decidualization of the human stroma. LRH-1 
activity can be modulated in hESC by the use of specific ligands, affecting the expression of 
direct target genes such as the decidual marker IGFBP1. Moreover, we provide for the first 
time evidence that LRH-1 promotes hESCs migration during the early stages of embryo 
apposition and adhesion to the endometrial epithelium. 
 
In order to extrapolate this results to the in vivo condition, and relate LRH-1 expression with 
implantation failure, further studies will have to be performed using human endometrial 
biopsy samples taken in different phases of the cycle from woman suffering from recurrent 
miscarriages. 
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